Evidence map›Paper›PMID 32265324›Full record

ArticlemBio2020

Modulation of the Gut Microbiota during High-Dose Glycerol Monolaurate-Mediated Amelioration of Obesity in Mice Fed a High-Fat Diet.

Minjie Zhao, Zengliang Jiang, Haiying Cai, Yang Li, Qiufen Mo, Lingli Deng, Hao Zhong, Tao Liu, Hui Zhang, Jing X Kang and 1 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Enhanced Effects of Complex Tea Extract and the Postbiotic BPL1International journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Frontiers in nutrition · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Ultra-processed foods and food additives in gut health and disease.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Minjie Zhao *College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Zengliang Jiang *Institute of Basic Medical Sciences, School of Life Sciences, Westlake University, Hangzhou, China.
Haiying CaiZhejiang Key Lab for Chem & Bio Processing Technology of Farm Product, Zhejiang University of Science and Technology, Hangzhou, China.
Yang LiCollege of Food Science and Engineering, Qingdao Agricultural University, Qingdao, China.
Qiufen MoCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Lingli DengCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Hao ZhongCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Tao LiuCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Hui ZhangCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.
Jing X KangLaboratory of Lipid Medicine and Technology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA kang.jing@mgh.harvard.edu fengfq@zju.edu.cn.
Fengqin FengCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China kang.jing@mgh.harvard.edu fengfq@zju.edu.cn.
Ministry of Agriculture and Rural Affairs · CNZhejiang University · CNHarvard University · USQingdao Agricultural University · CNWestlake University · CNZhejiang University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity and associated metabolic disorders are worldwide public health issues. The gut microbiota plays a key role in the pathophysiology of diet-induced obesity. Glycerol monolaurate (GML) is a widely consumed food emulsifier with antibacterial properties. Here, we explore the anti-obesity effect of GML (1,600 mg/kg of body weight) in high-fat diet (HFD)-fed mice. HFD-fed mice were treated with 1,600 mg/kg GML. Integrated microbiome, metabolome, and transcriptome analyses were used to systematically investigate the metabolic effects of GML, and antibiotic treatment was used to assess the effects of GML on the gut microbiota. Our data indicated that GML significantly reduced body weight and visceral fat deposition, improved hyperlipidemia and hepatic lipid metabolism, and ameliorated glucose homeostasis and inflammation in HFD-fed mice. Importantly, GML modulated HFD-induced gut microbiota dysbiosis and selectively increased the abundance of

Indexed as

Diet, High-FatAnimalsBifidobacteriumBody WeightDysbiosisGastrointestinal MicrobiomeHyperlipidemiasInflammationLauratesLipid MetabolismLiverMaleMetabolomeMiceMice, Inbred C57BLMonoglyceridesLauratesMonoglyceridesmonolauringlycerol monolaurategut microbiotahepatic transcriptomeobesityserum metabolome

Identifiers

PMID32265324
PMCPMC7157765
OpenAlexW3015133288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.